Filing Flows › Envoy Medical (COCH) › Q1 2026
Envoy Medical (COCH) Q1 2026 earnings results (first quarter 2026)
10-Q filed May 11, 2026
Envoy Medical (COCH) reported revenue of $39K for the first quarter 2026 (Q1 2026), -15% from a year earlier and -48% from the quarter before.
Envoy Medical, Q1 2026: revenue $39K (-15% year over year), net loss $4.4M, operating cash flow −$6.1M. The chart follows the revenue to costs, profit and cash.
| Q1 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $39K | -48% | -15% |
| Operating profit | −$6.0M | — | — |
| Net earnings | −$4.4M | — | — |
| Operating cash flow | −$6.1M | — | — |
What changed
Revenue was $39K in Q1 2026, down 15% year over year and down 48% from the previous quarter.
Operating costs exceeded revenue by $6.0M, an operating margin of -15279.5%. Total costs grew 16% against a revenue fall of 15%. The fastest-growing cost line was Cost of revenue (+38%). The quarter ended with a net loss of $4.4M, narrower than the previous quarter's $6.6M loss. Non-operating items added $1.6M, -37% of pre-tax earnings, so the bottom line overstates operating performance.
Operating cash flow was −$6.1M. Non-cash charges added back $73K of depreciation and $239K of share-based compensation. Working capital and other items used $2.0M.
Questions
What was Envoy Medical's revenue in the first quarter 2026?
Envoy Medical (COCH) reported revenue of $39K for the first quarter 2026 (Q1 2026), -15% from a year earlier and -48% from the quarter before.
Source: Envoy Medical 10-Q on SEC EDGAR.